Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer
|
Luke Timmerman |
11/05/09 |
Boston
|
|
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/05/09 |
Seattle
|
|
Amylin Forms Global Alliance in Obesity Drug Development; TEDMED’s Show Will Go On, Sequenom Sued for Civil Fraud, & More San Diego Biotech News
|
Bruce V. Bigelow |
11/05/09 |
San Diego
|
|
Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/04/09 |
Boston
|
|
Dendreon Files Provenge Application to FDA Ahead of Schedule, Now It’s Time to Wait
|
Luke Timmerman |
11/02/09 |
Seattle
|
|
Amylin, Lilly’s Byetta Wins FDA Approval as Standalone Therapy, Without Combo Drugs
|
Luke Timmerman |
10/30/09 |
San Diego
|
|
UK’s Enigma Looks to San Diego, Life Gets Sweeter for Senomyx, Arena Says Obesity Drug Is Not “Wimpy,” & More San Diego Life Sciences News
|
Denise Gellene |
10/29/09 |
San Diego
|
|
Stryker Biotech Division Indicted for FDA Fraud by Massachusetts Grand Jury
|
Luke Timmerman |
10/28/09 |
Boston
|
|
Interlace Gets FDA Clearance
|
Ryan McBride |
10/28/09 |
Boston
|
|
UK’s Enigma Diagnostics to Establish U.S. Headquarters in San Diego
|
Bruce V. Bigelow |
10/27/09 |
San Diego
|
|
Arena Positions Weight Loss Drug as the One That Won’t Raise Your Blood Pressure
|
Luke Timmerman |
10/27/09 |
San Diego
|
|
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding
|
Luke Timmerman |
10/26/09 |
Seattle
|
|
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/22/09 |
Seattle
|
|
Antigenics Shares Plummet as Cancer Vaccine Application Rejected in Europe
|
Luke Timmerman |
10/21/09 |
Boston
|
|
Pathway Medical Learns Lessons During Tougher Than Expected First Year on Market
|
Luke Timmerman |
10/20/09 |
Seattle
|
|
Amgen’s Dmab Faces FDA Delay
|
Luke Timmerman |
10/19/09 |
Seattle
|
|
Top 10 Highlights from FiReGlobal: Michael Dell, Lee Hartwell, Irwin Jacobs, and More
|
Gregory T. Huang |
10/16/09 |
Seattle
|
|
Alkermes Anti-Addiction Drug Fares Well in Clinical Trials, Amgen Takes Aim at Drug-Development Success Rate, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/14/09 |
Boston
|
|
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
Wireless Industry Foresees Capacity Constraints, Algae-Based Biofuels Still a Decade Away, Xconomy San Diego Marks its First Anniversary, & More San Diego BizTech News
|
Bruce V. Bigelow |
10/13/09 |
San Diego
|
|
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent
|
Luke Timmerman |
10/09/09 |
National
|
|
Public Biotechs’ Finances Foundering, Epizyme Banks $32M, Paratek Cuts Deal with Novartis, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/09/09 |
Boston
|
|
Justice Department Joins Sequenom Probe, Accumetrics Raises $16.5, Transdel’s Topical Pain Reliever Gets Mixed Results, & More San Diego Life Sciences News
|
Denise Gellene |
10/08/09 |
San Diego
|
|
Gary West on San Diego’s West Wireless Health Institute and ‘Always On’ Medicine
|
Bruce V. Bigelow |
10/07/09 |
San Diego
|
|
DC Matters, But Biotech Can’t Neglect City Hall
|
David Miller |
10/07/09 |
Seattle
|
|
Gen-Probe Pays $60M for Prodesse
|
Bruce V. Bigelow |
10/06/09 |
San Diego
|
|
Genzyme Drug Fails to Win FDA Nod
|
Luke Timmerman |
10/06/09 |
Boston
|
|
Transdel’s Topical Pain Reliever Falls Short on One Goal, Hits Another
|
Luke Timmerman |
10/06/09 |
San Diego
|
|
“Don’t Touch My Bags If You Please, Mr. Customs Man”
|
Stewart Lyman |
10/05/09 |
Seattle
|
|
Marval Biosciences, San Diego’s Latest Virtual Biomedical Startup, Raises $2.5M to Develop Next-Generation Contrast Agents for Medical Imaging
|
Bruce V. Bigelow |
10/02/09 |
San Diego
|
|
Page 1 of
14 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
